DOI:10.18643/gieu.2016.15
"> DOI:10.18643/gieu.2016.15
"> DOI:10.18643/gieu.2016.15
"/> National genetic screening for endometrial cancer
<- Home <- Arhive <- Vol. 12, Issue 1, March 2016



GINECOeu12(1)15-18(2016)
© gineco.eu


National genetic screening for endometrial cancer

R. Bohiltea, V. Radoi, N. Turcan, M. Cirstoiu


Abstract: Endometrial cancer is the most common gynecologic malignancy in developed countries, with an average incidence of 14.7/100,000 women and ranks second place after cervical cancer in developing countries, with an average incidence of 5.5/100,000. The global average incidence in 2012 was 8.2/100,000 women, representing 319 605 cases of cancer of the endometrium. The reported incidence in 2012 of cancer of the endometrium for Romania was 8.46/100000 women, within Europe the same year average was 13.6/100,000 women. In Romania, pick the incidence occurs in the age group 60-64 years (42.8/100,000 women), the cumulative risk being 1%. According to World Health Organization predictive estimates for Romania is expected for 2015 an increase in the number of new cases by 2.92% to 10.07% for 2025 and for 2035 with 15.33%, of whom, under the age of 65 years in 2015 will be 990 new cases, in 2025 will be 986 new cases and in 2035 under this age will be 1027 new cases of cancer of the endometrium. The data for the period 2005-2015 was investigated coming from reports of family doctors, the national registry for cancer and (SIUI). Of the total of admissions for diagnosed endometrial cancer, 10% have affected women under 50 years, and 2.78% women under 40 years. Studying the National Registry for Cancer for 2005-2007, regarding new cases reported by district oncology cabinets, an average number of 108 new endometrial cancer cases/year has resulted and respectively 237 new colorectal cancer cases for women under 50. The total number is significant, representing the patients whose genetic testing is essential for defining an important high risk group for familial cancer, a fact that is universally accepted, the screening which is intended for.
DOI:10.18643/gieu.2016.15

Keywords: Lynch syndrome, Cowden syndrome, MMR genes, endometrial cancer.

Full Text in PDF
© 2008-2024 gineco.eu. All rights reserved
created by if else factory